Craft

Thermo Fisher Scientific

Stock Price

$547.8

2024-10-29

Market Capitalization

$209.2 B

2024-10-29

Revenue

$42.9 B

FY, 2024

Thermo Fisher Scientific Summary

Company Summary

Overview
Thermo Fisher Scientific is a biotechnology company engaged in service science. It operates in four business segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The Laboratory Products and Biopharma Services segment offers products and services for life science research and drug discovery and development. The Life Sciences Solutions segment provides reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. The Analytical Instruments segment specializes in instruments, supporting consumables, software, and services for chromatography, mass spectrometry, chemical analysis, and electron microscopy. The Specialty Diagnostics segment delivers test kits, reagents, culture media, instruments, and associated products for clinical diagnostics, microbiology, and transplant diagnostics.
Type
Public
Status
Active
Founded
1956
HQ
Waltham, MA, US | view all locations
Website
https://www.thermofisher.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Marc N. Casper

    Marc N. Casper, Chairman, President and Chief Executive Officer

  • Alan Sachs

    Alan Sachs, Chief Medical Officer

  • Karen E. Nelson

    Karen E. Nelson, Chief Scientific Officer

  • Michel Lagarde

    Michel Lagarde, Executive Vice President and Chief Operating Officer

Operating MetricsView all

Remaining Performance Obligations

$25.3B
5.6%

Q3, 2024

Countries

70

FY, 2023

LocationsView all

455 locations detected

  • Waltham, MA HQ

    United States

    168 3rd Ave

  • Agawam, MA

    United States

    325 Bowles Rd

  • Allentown, PA

    United States

    7554 Schantz Rd

  • Ann Arbor, MI

    United States

    110 Miller Ave

  • Asheville, NC

    United States

    275 Aiken Rd

  • Auburn, AL

    United States

    2039 McMillan St

and 449 others

Thermo Fisher Scientific Financials

Summary Financials

Revenue (Q1, 2025)
$10.4B
Gross profit (Q1, 2025)
$4.2B
Net income (Q1, 2025)
$1.5B
Cash (Q1, 2025)
$4.1B
EBIT (Q1, 2025)
$1.7B
Enterprise value
$239.3B

Footer menu